BioCentury | Oct 30, 2017
Company News

Management Tracks: Biohaven, Selecta

...NASDAQ:PRQR) said CMO Noreen Henig will resign, effective Nov. 4. Chief Development Strategy Officer David Rodman...
BioCentury | Apr 20, 2017
Financial News

Sorrento completes follow-on

...in a follow-on underwritten by Cantor Fitzgerald, FBR Capital Markets, Oppenheimer, Aegis Capital, Joseph Gunnar, Rodman...
BioCentury | Apr 1, 2017
Company News

Management tracks

...Inc. (NYSE:Q). RNA play ProQR Therapeutics N.V. (NASDAQ:PRQR) named David Rodman chief development strategy officer. Rodman...
BioCentury | Mar 9, 2017
Financial News

BeyondSpring raises $54.3M in downsized IPO, placement

...$50.8 million through the sale of 2.5 million shares at $20 in the placement. The Rodman...
BioCentury | Jan 27, 2017
Company News

Nivalis restructuring

...headcount reduction will include President and CEO Jon Congleton, CMO and EVP of Discovery David Rodman...
BioCentury | Jan 5, 2017
Financial News

Financial tracks

...was a senior director at Merck Serono Ventures prior to joining Novo Ventures in 2015. Rodman...
BioCentury | Jun 8, 2016
Financial News

VBL raises $24M after boost from ovarian cancer data

...of 4.4 million shares at $5.50 in a registered direct offering with institutional investors. The Rodman...
BioCentury | Aug 4, 2015
Financial News

Financial tracks

...The Rodman & Renshaw unit of H.C. Wainwright & Co. hired Raghuram Selvaraju as managing director...
BioCentury | Apr 28, 2015
Financial News

Financial tracks

...and specialty pharmaceuticals. Higgins was a managing director and a senior specialty pharmaceuticals analyst at Rodman...
BioCentury | Mar 31, 2014
Company News

miRagen management update

...miRagen Therapeutics Inc. , Boulder, Colo. Business: Cardiovascular Hired: David Rodman as EVP of R&D, formerly...
Items per page:
1 - 10 of 798
BioCentury | Oct 30, 2017
Company News

Management Tracks: Biohaven, Selecta

...NASDAQ:PRQR) said CMO Noreen Henig will resign, effective Nov. 4. Chief Development Strategy Officer David Rodman...
BioCentury | Apr 20, 2017
Financial News

Sorrento completes follow-on

...in a follow-on underwritten by Cantor Fitzgerald, FBR Capital Markets, Oppenheimer, Aegis Capital, Joseph Gunnar, Rodman...
BioCentury | Apr 1, 2017
Company News

Management tracks

...Inc. (NYSE:Q). RNA play ProQR Therapeutics N.V. (NASDAQ:PRQR) named David Rodman chief development strategy officer. Rodman...
BioCentury | Mar 9, 2017
Financial News

BeyondSpring raises $54.3M in downsized IPO, placement

...$50.8 million through the sale of 2.5 million shares at $20 in the placement. The Rodman...
BioCentury | Jan 27, 2017
Company News

Nivalis restructuring

...headcount reduction will include President and CEO Jon Congleton, CMO and EVP of Discovery David Rodman...
BioCentury | Jan 5, 2017
Financial News

Financial tracks

...was a senior director at Merck Serono Ventures prior to joining Novo Ventures in 2015. Rodman...
BioCentury | Jun 8, 2016
Financial News

VBL raises $24M after boost from ovarian cancer data

...of 4.4 million shares at $5.50 in a registered direct offering with institutional investors. The Rodman...
BioCentury | Aug 4, 2015
Financial News

Financial tracks

...The Rodman & Renshaw unit of H.C. Wainwright & Co. hired Raghuram Selvaraju as managing director...
BioCentury | Apr 28, 2015
Financial News

Financial tracks

...and specialty pharmaceuticals. Higgins was a managing director and a senior specialty pharmaceuticals analyst at Rodman...
BioCentury | Mar 31, 2014
Company News

miRagen management update

...miRagen Therapeutics Inc. , Boulder, Colo. Business: Cardiovascular Hired: David Rodman as EVP of R&D, formerly...
Items per page:
1 - 10 of 798